Clinical Trial Update: Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: "QOL Survey in Premenopausal Breast Cancer Patients"

View source ↗

Summary

Completed clinical trial update presenting results from a quality-of-life survey in premenopausal breast cancer patients treated with Leuplin SR 11.25 mg Inject…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Leuplin SR 11.25 mg Injection Kit (leuprolide acetate)

Snippet

Sponsor: Takeda | Conditions: Breast Cancer | Status: COMPLETED | Results posted: 2016-10-18